Literature DB >> 2196302

Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis.

A M Irani1, S I Butrus, K F Tabbara, L B Schwartz.   

Abstract

The distribution and concentration of human tryptase-positive, chymase-negative mast cells (MCTS) and tryptase-positive, chymase-positive mast cells (MCTCS) were examined in conjunctival biopsy specimens from subjects with active vernal conjunctivitis (VC; n = 7), giant papillary conjunctivitis (GPC; n = 6), and allergic conjunctivitis (AC; n = 5), and from asymptomatic soft-contact lens wearers (SCL; n = 6) and normal control individuals (n = 19). Carnoy's fixed tissue sections were stained by a double immunohistochemical method using a biotinylated mouse monoclonal antichymase antibody with immunoperoxidase, followed by an alkaline phosphatase-conjugated mouse monoclonal antitryptase antibody. Epithelial mast cells (MCs) were found in all VC specimens (96% MCTCs) and in three GPC specimens (100% MCTCS) but in none of the other groups. In the substantia propria, MCTCS were the predominant type of MC observed in all specimens, accounting for 95% of the total MCs in the normal control group and 100% of the total MCs in the subjects with GPC, AC, and SCL. No significant differences were found in the total MC concentration of the substantia propria among the normal control subjects (11,054 +/- 6327 MCs per cubic millimeter), subjects in the SCL group (13,168 +/- 4685 MCs per cubic millimeter), subjects with GPC (17,313 +/- 8500 MCs per cubic millimeter), and subjects with AC (15,380 +/- 5660 MCs per cubic millimeter). In subjects with VC, the percentage of MCTs (18% +/- 13%) and the total MC concentration (24,689 +/- 18,978 MCs per cubic millimeter) in the substantia propria were significantly increased as compared to the normal control group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196302     DOI: 10.1016/s0091-6749(05)80120-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  21 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 3.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

Review 4.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

5.  Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis.

Authors:  K F Tabbara; S A al-Kharashi
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

Review 6.  T helper subsets in allergic eye disease.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

7.  Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue.

Authors:  S Finotto; J Dolovich; J A Denburg; M Jordana; J S Marshall
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

Authors:  M el Hennawi
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

9.  Mast cell gastritis: children complaining of chronic abdominal pain with histologically normal gastric mucosal biopsies except for increase in mast cells, proposing a new entity.

Authors:  Fatemeh E Mahjoub; Fatemeh Farahmand; Zahra Pourpak; Hoda Asefi; Zahra Amini
Journal:  Diagn Pathol       Date:  2009-10-03       Impact factor: 2.644

10.  Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model.

Authors:  Kouhei Okada; Tetsuya Sugiyama; Shinji Takai; Denan Jin; Osamu Ishida; Masanori Fukmoto; Hidehiro Oku; Mizuo Miyazaki; Tsunehiko Ikeda
Journal:  Mol Vis       Date:  2009-10-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.